Stock Comparison

BMRN vs REGN

Biomarin Pharmaceutical Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BMRN

Biomarin Pharmaceutical Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.29B

$80.55B

P/E (TTM)

171.6

19.4

Forward P/E

12.8

17.1

Price/Sales

3.6

5.2

Price/Book

1.9

2.5

EV/EBITDA

40.6

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

8.29%

29.65%

Operating Margin

13.55%

24.32%

Return on Equity

1.18%

14.00%

Return on Assets

3.26%

6.53%

Growth (YoY)

Revenue Growth

19.90%

16.70%

Earnings Growth

-81.30%

-4.50%

Price & Risk

Beta

0.2

52-Week High

$70.24

$810.12

52-Week Low

$49.67

$553.38

Analyst Target

$88.16

$833.54

Compare BMRN and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.